Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022

Derek Archila Upgraded (BPMC) to Hold and Held Target at $41 on, Jan 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-41-on-jan-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Upgraded "Blueprint Medicines Corporation" (BPMC) to Hold and Held Target at $41 on, Jan 3rd, 2023.

Derek has made no other calls on BPMC in the last 4 months.



There are 11 other peers that have a rating on BPMC. Out of the 11 peers that are also analyzing BPMC, 4 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Maintained at Hold with Decreased Target to $53 on, Monday, December 12th, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $52 on, Wednesday, November 2nd, 2022
  • Matthew Biegler of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, November 2nd, 2022
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $75 on, Wednesday, November 2nd, 2022


These are the ratings of the 7 analyists that currently disagree with Derek


  • Ami Fadia of "Needham" Initiated at Strong Buy and Held Target at $60 on, Wednesday, December 14th, 2022
  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $114 on, Friday, November 4th, 2022
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $108 on, Thursday, November 3rd, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $70 on, Wednesday, November 2nd, 2022
  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $106 on, Wednesday, November 2nd, 2022
  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Decreased Target to $85 on, Wednesday, November 2nd, 2022
  • Zhiqiang Shu of "Berenberg" Initiated at Strong Buy and Held Target at $90 on, Wednesday, September 14th, 2022

Publication Contributing Sources